Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rivaroxaban”

425 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 425 results

Not applicableUnknownNCT04315974
What this trial is testing

Italian Registry In the Setting of AF Ablation With Rivaroxaban (IRIS)

Who this might be right for
Atrial Fibrillation
Dr Carlo Lavalle 250
Not applicableUnknownNCT04042155
What this trial is testing

Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)

Who this might be right for
Atrial FibrillationRecurrent Venous Thromboembolism
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,600
Not applicableStudy completedNCT04174859
What this trial is testing

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment

Who this might be right for
Non-valvular Atrial Fibrillation
Bayer 812
Not applicableStudy completedNCT02464488
What this trial is testing

New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study

Who this might be right for
Atrial Fibrillation
Hôpital Charles Foix 232
Early research (Phase 1)Study completedNCT02537405
What this trial is testing

Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects

Who this might be right for
Embolism, Atrial Fibrillation and Venous Thrombosis
Bayer 40
Testing effectiveness (Phase 2)Ended earlyNCT04128956
What this trial is testing

Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS

Who this might be right for
Venous ThrombosesStent Stenosis
University of Zurich 172
Not applicableStudy completedNCT01598051
What this trial is testing

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 741
Large-scale testing (Phase 3)UnknownNCT05700266
What this trial is testing

Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis

Who this might be right for
Ischemic StrokeIntracranial AtherosclerosisStenosis
The First Affiliated Hospital with Nanjing Medical University 1,180
Post-approval studies (Phase 4)Study completedNCT03718429
What this trial is testing

Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

Who this might be right for
Coronary Artery DiseasePeripheral Arterial DiseaseAtrial Fibrillation
University of Florida 86
Early research (Phase 1)Study completedNCT01507051
What this trial is testing

Switching Study From Warfarin to Rivaroxaban

Who this might be right for
Venous Thrombosis
Bayer 96
Not applicableNot Yet RecruitingNCT05900388
What this trial is testing

Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

Who this might be right for
Venous ThromboembolismChildren Under 2 Years
Bayer 850
Testing effectiveness (Phase 2)Active Not RecruitingNCT04755283
What this trial is testing

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)Stroke
Anthos Therapeutics, Inc. 1,287
Testing effectiveness (Phase 2)Study completedNCT00398905
What this trial is testing

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 726
Post-approval studies (Phase 4)UnknownNCT02666157
What this trial is testing

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
National Cheng-Kung University Hospital 3,672
Post-approval studies (Phase 4)Study completedNCT01812200
What this trial is testing

Antithrombotic Triple Therapy in Humans

Who this might be right for
Atrial FibrillationAcute Coronary Syndrome
Medical University of Vienna 60
Not applicableStudy completedNCT01743898
What this trial is testing

A Prospective Pharmacodynamic Study of Rivaroxaban

Who this might be right for
Blood Clot
University of North Carolina, Chapel Hill 65
Not applicableStudy completedNCT02468102
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Who this might be right for
Acute Coronary SyndromeVenous ThrombosisPulmonary Embolism+1 more
Bayer 99,999
Post-approval studies (Phase 4)Study completedNCT01989845
What this trial is testing

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Who this might be right for
RivaroxabanCancer-associated ThrombosisRecurrence+1 more
Seoul National University Hospital 127
Early research (Phase 1)Study completedNCT06558045
What this trial is testing

Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets

Who this might be right for
Healthy
Dexa Medica Group 26
Early research (Phase 1)Study completedNCT01656330
What this trial is testing

Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers

Who this might be right for
Healthy
Janssen Research & Development, LLC 35
Load More Results